Clinical Trial Update: Defining Late Onset Occult Asymptomatic Cardiotoxicity in Childhood Cancer Survivors Exposed to Anthracycline Therapy

View source ↗

Summary

A completed clinical trial defining late-onset occult asymptomatic cardiotoxicity in childhood cancer survivors who were treated with anthracycline therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease

Snippet

Sponsor: Connecticut Children's Medical Center | Conditions: Cardiovascular Disease | Status: COMPLETED